NASDAQ : QNTM
Quantum BioPharma Ltd. — Financial statements
Healthcare · Biotechnology · Canada
Last price 2.44 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 20.66M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 7.49M | 9.05M | 9.41M | 9.03M | 14.45M | 15.93M |
| Research & Development | 1.58M | 2.76M | 6.08M | 3.86M | 6.91M | 6.33M |
| Operating Expenses | 12.31M | 15.30M | 16.14M | 19.23M | 27.43M | 33.74M |
| Operating Income | -12.31M | -15.30M | -16.14M | -19.23M | -27.43M | -33.74M |
| Interest Expense | -1.81M | -2.11M | -47.58K | -299.00 | -48.82K | -69.40K |
| Interest & Investment Income | 78.14K | 236.08K | 572.89K | 786.36K | 367.74K | 1.29K |
| Other Non Operating Income (Expenses) | -14.14M | -12.61M | -33.30K | 212.26K | 521.81K | 682.51K |
| EBT Excluding Unusual Items | -28.18M | -29.78M | -15.64M | -18.24M | -26.59M | -33.13M |
| Gain (Loss) on Sale of Investments | 140.56K | 433.15K | -3.70K | -378.43K | -234.23K | -858.48K |
| Asset Writedown | -4.56M | |||||
| Legal Settlements | 2.35M | 2.35M | ||||
| Other Unusual Items | 394.71K | 43.34K | 732.42K | 4.94M | 119.45K | 49.79K |
| Pretax Income | -25.30M | -26.96M | -14.92M | -18.23M | -26.70M | -33.94M |
| Earnings From Continuing Operations | -25.30M | -26.96M | -14.92M | -18.23M | -26.70M | -33.94M |
| Earnings From Discontinued Operations | 3.10M | -1.35M | ||||
| Net Income to Company | -25.30M | -26.96M | -14.92M | -18.23M | -23.61M | -35.29M |
| Minority Interest in Earnings | 138.37K | 781.55K | 712.80K | 328.41K | ||
| Net Income | -25.16M | -26.18M | -14.20M | -17.90M | -23.61M | -35.29M |
| Net Income to Common | -25.16M | -26.18M | -14.20M | -17.90M | -23.61M | -35.29M |
| Shares Outstanding (Basic) | 4.70M | 3.29M | 1.14M | 609.06K | 595.88K | 537.62K |
| Shares Outstanding (Diluted) | 4.70M | 3.29M | 1.14M | 609.06K | 595.88K | 537.62K |
| EPS (Basic) | -5.35 | -7.97 | -12.49 | -29.39 | -39.62 | -65.63 |
| EPS (Diluted) | -5.35 | -7.97 | -12.49 | -29.39 | -39.62 | -65.63 |
| Free Cash Flow | -5.49M | -8.24M | -6.88M | -10.83M | -28.45M | -20.75M |
| Free Cash Flow Per Share | -1.17 | -2.51 | -6.05 | -17.78 | -47.74 | -38.59 |
| EBITDA | -11.78M | -14.76M | -15.65M | -16.73M | -22.90M | -29.70M |
| D&A For EBITDA | 530.51K | 545.78K | 490.57K | 2.51M | 4.53M | 4.05M |
| EBIT | -12.31M | -15.30M | -16.14M | -19.23M | -27.43M | -33.74M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 3.65M | 1.91M | 6.00M | 2.76M | 16.98M | 35.26M |
| Short-Term Investments | 210.71K | 459.08K | 1.20M | 756.10K | 158.04K | |
| Cash & Short-Term Investments | 3.86M | 2.36M | 7.20M | 3.51M | 16.98M | 35.42M |
| Accounts Receivable | 3.43M | 7.19M | 23.19K | |||
| Other Receivables | 107.63K | 231.05K | 374.68K | 228.76K | 374.38K | 500.96K |
| Receivables | 107.63K | 231.05K | 3.81M | 7.42M | 397.56K | 500.96K |
| Inventory | 53.01K | 52.13K | 117.24K | |||
| Prepaid Expenses | 55.31K | 15.29K | 42.69K | 124.71K | 163.63K | 763.92K |
| Other Current Assets | 5.89M | 3.82M | 887.58K | 30.70K | 308.50K | 9.25M |
| Total Current Assets | 9.96M | 6.48M | 12.05M | 11.09M | 17.85M | 45.93M |
| Property, Plant & Equipment | 125.89K | 169.35K | 130.38K | 120.42K | 260.93K | 168.31K |
| Long-Term Investments | 2.22K | 6.05K | 827.61K | 660.23K | ||
| Other Intangible Assets | 4.30M | 4.51M | 4.93M | 5.36M | 12.04M | 16.20M |
| Long-Term Accounts Receivable | 907.37K | 7.43M | ||||
| Total Assets | 14.39M | 11.16M | 17.12M | 17.47M | 38.41M | 62.96M |
| Accounts Payable | 2.08M | 1.98M | 3.25M | 3.24M | 2.76M | 3.00M |
| Accrued Expenses | 1.30M | 2.20M | 1.11M | 954.37K | 4.35M | 4.46M |
| Short-Term Debt | 300.55K | 1.30M | 619.03K | 300.55K | 300.55K | 300.55K |
| Current Portion of Long-Term Debt | 597.84K | 472.50K | 152.11K | |||
| Current Portion of Leases | 64.92K | 103.17K | 53.78K | 38.65K | 177.87K | 124.31K |
| Current Unearned Revenue | 1.00M | |||||
| Other Current Liabilities | 3.95M | 492.00K | 31.34K | 243.59K | 825.10K | |
| Total Current Liabilities | 8.30M | 6.06M | 6.68M | 4.57M | 7.83M | 8.70M |
| Long-Term Leases | 38.00K | 131.04K | ||||
| Total Liabilities | 8.30M | 6.06M | 6.68M | 4.57M | 7.87M | 8.83M |
| Common Stock | 188.02M | 169.70M | 150.47M | 137.78M | 143.41M | 152.32M |
| Additional Paid-In Capital | 34.75M | 35.41M | 31.07M | 30.23M | 28.50M | 22.58M |
| Retained Earnings | -215.10M | -198.29M | -172.11M | -157.91M | -144.16M | -126.15M |
| Comprehensive Income & Other | 269.80K | 101.54K | 2.05M | 3.14M | 2.80M | 5.38M |
| Total Common Equity | 7.95M | 6.92M | 11.48M | 13.24M | 30.54M | 54.13M |
| Minority Interest | -1.86M | -1.82M | -1.04M | -327.50K | ||
| Shareholders' Equity | 6.09M | 5.10M | 10.44M | 12.91M | 30.54M | 54.13M |
| Total Liabilities & Equity | 14.39M | 11.16M | 17.12M | 17.47M | 38.41M | 62.96M |
| Total Debt | 963.31K | 1.88M | 824.92K | 339.20K | 516.42K | 555.90K |
| Net Cash (Debt) | 2.89M | 488.23K | 6.37M | 3.17M | 16.46M | 34.86M |
| Net Cash Per Share | 0.62 | 0.15 | 5.61 | 5.21 | 27.63 | 64.84 |
| Filing Date Shares Outstanding | 8.09M | 5.83M | 2.71M | 617.18K | 625.29K | 592.18K |
| Total Common Shares Outstanding | 7.58M | 3.89M | 2.30M | 605.80K | 592.37K | 622.32K |
| Working Capital | 1.66M | 420.06K | 5.37M | 6.52M | 10.02M | 37.23M |
| Book Value Per Share | 1.05 | 1.78 | 4.99 | 21.85 | 51.56 | 86.98 |
| Tangible Book Value | 3.64M | 2.41M | 6.55M | 7.88M | 18.50M | 37.93M |
| Tangible Book Value Per Share | 0.48 | 0.62 | 2.85 | 13.01 | 31.23 | 60.95 |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -25.16M | -26.18M | -14.20M | -17.90M | -23.61M | -35.29M |
| Depreciation & Amortization | 530.51K | 545.78K | 490.57K | 2.51M | 4.53M | 4.05M |
| Other Amortization | 1.49M | 1.49M | ||||
| Loss (Gain) From Sale of Assets | 117.14K | 117.14K | ||||
| Asset Writedown & Restructuring Costs | 4.56M | |||||
| Loss (Gain) From Sale of Investments | -140.56K | -433.15K | 3.70K | 378.43K | 234.23K | 858.48K |
| Stock-Based Compensation | 2.71M | 2.95M | 152.21K | 3.84M | 1.53M | 7.44M |
| Other Operating Activities | 10.93M | 11.29M | -3.08M | -5.84M | -2.76M | 684.58K |
| Change in Accounts Receivable | 138.62K | 196.68K | -145.91K | 159.59K | 215.18K | -106.88K |
| Change in Inventory | 23.86K | 65.11K | -117.24K | |||
| Change in Accounts Payable | 2.38M | 1.18M | 4.27M | 2.05M | -699.78K | 3.60M |
| Change in Unearned Revenue | -1.00M | 1.00M | ||||
| Change in Other Net Operating Assets | 1.50M | 1.54M | 4.75M | -571.58K | -6.64M | -609.15K |
| Operating Cash Flow | -5.49M | -8.24M | -6.88M | -10.83M | -28.33M | -20.75M |
| Capital Expenditures | -113.96K | |||||
| Cash Acquisitions | 31.78K | 768.96K | ||||
| Sale (Purchase) of Intangibles | -250.00K | -500.00K | ||||
| Investment in Securities | -40.24K | 1.18M | -500.56K | -744.50K | -243.58K | |
| Other Investing Activities | -3.46M | -3.13M | -1.00M | 443.14K | 12.73M | |
| Investing Cash Flow | -3.50M | -1.95M | -1.50M | -269.58K | 12.12M | 268.96K |
| Short-Term Debt Issued | 2.11M | 309.14K | ||||
| Long-Term Debt Issued | 3.24M | 702.70K | ||||
| Total Debt Issued | 3.02M | 5.36M | 1.01M | |||
| Short-Term Debt Repaid | -1.50M | -71.76K | ||||
| Long-Term Debt Repaid | -113.86K | -63.59K | -189.05K | -143.07K | -57.57K | |
| Lease Payments | -99.63K | -113.86K | -63.59K | -189.05K | -143.07K | -57.57K |
| Total Debt Repaid | -1.81M | -1.61M | -63.59K | -189.05K | -143.07K | -129.32K |
| Net Debt Issued (Repaid) | 1.20M | 3.75M | 948.25K | -189.05K | -143.07K | -129.32K |
| Issuance of Common Stock | 8.21M | 529.67K | 10.67M | 20.28K | 38.34M | |
| Repurchase of Common Stock | -2.96M | -1.93M | ||||
| Other Financing Activities | 1.72M | 1.82M | ||||
| Financing Cash Flow | 11.13M | 6.10M | 11.62M | -3.13M | -2.07M | 38.21M |
| Net Cash Flow | 2.15M | -4.09M | 3.24M | -14.22M | -18.28M | 17.73M |
| Free Cash Flow | -5.49M | -8.24M | -6.88M | -10.83M | -28.45M | -20.75M |
| Free Cash Flow Per Share | -1.17 | -2.51 | -6.05 | -17.78 | -47.74 | -38.59 |
| Levered Free Cash Flow | -5.03M | -6.83M | -5.13M | -15.51M | -2.75M | -8.19M |
| Unlevered Free Cash Flow | -5.39M | -7.00M | -5.10M | -15.51M | -2.72M | -8.15M |
| Free Cash Flow After Leases | -5.59M | -8.35M | -6.94M | -11.02M | -28.59M | -20.80M |
| Change in Working Capital | 4.04M | 1.99M | 9.76M | 1.64M | -7.12M | 2.89M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 19.14M | 27.99M | 7.09M | 36.22M | 30.36M | 41.25M |
| Enterprise Value | 16.24M | 28.32M | -85.88K | 32.12M | 7.17M | 2.33M |
| Last Close Price | 2.38 | 7.30 | 3.68 | 59.79 | 51.25 | 66.30 |
| PB Ratio | 2.27 | 5.49 | 0.68 | 2.81 | 0.99 | 0.76 |
| P/TBV Ratio | 5.62 | 11.61 | 1.08 | 4.60 | 1.64 | 1.09 |
| Debt / Equity Ratio | 0.16 | 0.37 | 0.08 | 0.03 | 0.02 | 0.01 |
| Net Debt / Equity Ratio | -0.47 | -0.10 | -0.61 | -0.25 | -0.54 | -0.64 |
| Net Debt / EBITDA Ratio | 0.25 | 0.03 | 0.41 | 0.19 | 0.72 | 1.17 |
| Net Debt / FCF Ratio | 0.53 | 0.06 | 0.93 | 0.29 | 0.58 | 1.68 |
| Quick Ratio | 0.48 | 0.43 | 1.65 | 2.39 | 2.22 | 4.13 |
| Current Ratio | 1.20 | 1.07 | 1.80 | 2.43 | 2.28 | 5.28 |
| Return on Equity (ROE) | -621.46% | -346.87% | -127.76% | -83.91% | -63.08% | -75.05% |
| Return on Assets (ROA) | -51.84% | -67.64% | -58.31% | -43.02% | -33.82% | -40.20% |
| Return on Capital Employed (ROCE) | -202.00% | -299.90% | -154.60% | -149.00% | -89.70% | -62.20% |
| Earnings Yield | -236.89% | -93.51% | -200.29% | -49.43% | -77.76% | -85.55% |
| FCF Yield | -26.77% | -29.43% | -96.97% | -29.89% | -93.71% | -50.30% |
| Buyback Yield / Dilution | -114.18% | -189.01% | -86.67% | -2.21% | -10.84% | -190.15% |